Calcium antagonists for congestive heart failure: is it really one bridge too far to cross?

Suppr

超能文献

作者信息

Opie L H

出版信息

Cardiovasc Drugs Ther. 1993 Feb;7(1):93-4. doi: 10.1007/BF00878314.

DOI:10.1007/BF00878314

PMID:8485072

Abstract

摘要

相似文献

Calcium antagonists for congestive heart failure: is it really one bridge too far to cross?

Cardiovasc Drugs Ther. 1993 Feb;7(1):93-4. doi: 10.1007/BF00878314.

Calcium antagonists for congestive heart failure: evolving concepts in bridge building.

Cardiovasc Drugs Ther. 1993 Feb;7(1):95-6. doi: 10.1007/BF00878315.

[Calcium channel blockers and mild congestive heart failure: advantage or disadvantage?].

Duodecim. 1991;107(22):1872-5.

Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents.

Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1645. doi: 10.1016/0002-9149(85)90995-6.

Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.

Circulation. 1987 Jun;75(6 Pt 2):V56-64.

The role of calcium antagonists in the treatment of chronic heart failure.

Eur Heart J. 1993 Jul;14 Suppl A:38-44. doi: 10.1093/eurheartj/14.suppl_a.38.

[Calcium antagonists in the treatment of congestive heart failure].

Klin Med (Mosk). 1987 Feb;65(2):20-7.

Calcium antagonists: new therapy for congestive heart failure?

Chest. 1987 Jan;91(1):1-3. doi: 10.1378/chest.91.1.1b.

[The role of calcium antagonists in the therapy of congestive heart failure].

G Ital Cardiol. 1998 Jul;28(7):818-23.

[Therapy of heart failure with calcium channel blockers?].

Herz. 1995 Aug;20 Suppl 2:1-2.

引用本文的文献

Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine.

Cardiovasc Drugs Ther. 1995 Oct;9(5):657-63. doi: 10.1007/BF00878548.

Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.

Drugs. 1995 Sep;50(3):560-86. doi: 10.2165/00003495-199550030-00009.

Cardioselectivity of calcium antagonists.

Cardiovasc Drugs Ther. 1994 May;8 Suppl 2:353-64. doi: 10.1007/BF00877320.

Eur J Clin Pharmacol. 1995;48(1):1-7. doi: 10.1007/BF00202163.

本文引用的文献

Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure.

Cardiovasc Drugs Ther. 1993 Feb;7(1):103-10. doi: 10.1007/BF00878317.

Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.

Circulation. 1987 Jun;75(6 Pt 2):V56-64.

Atrial natriuretic peptide secretion: synergistic effect of phorbol ester and A23187.

Biochem Biophys Res Commun. 1985 Dec 17;133(2):581-8. doi: 10.1016/0006-291x(85)90945-3.

The effect of diltiazem on mortality and reinfarction after myocardial infarction.

N Engl J Med. 1988 Aug 18;319(7):385-92. doi: 10.1056/NEJM198808183190701.

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

BMJ. 1989 Nov 11;299(6709):1187-92. doi: 10.1136/bmj.299.6709.1187.

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II).

Am J Cardiol. 1990 Oct 1;66(10):779-85. doi: 10.1016/0002-9149(90)90351-z.

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

N Engl J Med. 1991 Aug 1;325(5):303-10. doi: 10.1056/NEJM199108013250502.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验